Related Experiment Video
Updated: Jul 22, 2026

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
Published on: October 29, 2020
Sub-minimal inhibitory concentrations of cefmetazole enhance serum bactericidal activity in vitro by amplifying
1Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510.
Abstract:
Serum-resistant organisms grown in sub-minimal inhibitory concentrations (subMICs) of antibiotics in vitro may be rendered sensitive to complement-mediated, serum bactericidal activity. We measured 125I-C3 and 125I-C9 deposition on genetically serum resistant Salmonella montevideo SH5770 (SH5770) that was rendered serum sensitive by growth in sub-MICs of cefmetazole (CMZ), a parenteral, second generation, cephamycin-group antibiotic. Three times as much C3 and over six times as much C9 bound to SH5770 grown in one-fourth the MIC of CMZ compared to broth-grown bacteria. SDS-PAGE analysis and autoradiography showed that neither the ratio of C3b:iC3b (approximately 1:2.5) nor the nature of the C3-bacterial bond was changed by growing the organisms in CMZ. Large amounts of complement membrane attack complexes containing poly-C9 were seen only on CMZ-grown SH5770 by SDS-PAGE and autoradiography. Poly-C9 was also detected only on CMZ-grown bacteria by indirect immunofluorescence and ELISA using a murine monoclonal antibody directed against a neoantigen of poly-C9. Bacterial hydrophobicity increased after growth in CMZ, and transmission electron micrographs of CMZ-grown SH5770 showed cell wall disruption and blebbing. These results indicate that growth in subMICs of CMZ increases bacterial hydrophobic domains available for interacting with the membrane attack complex, C5b-9, allowing formation and stable insertion of bactericidal complexes containing poly-C9.
Insights
Growth in sub-minimal inhibitory concentrations of cefmetazole (CMZ) renders serum-resistant bacteria sensitive to complement-mediated killing. This occurs due to increased bacterial hydrophobicity and enhanced formation of bactericidal membrane attack complexes containing poly-C9.
Area of Science:
- Microbiology
- Immunology
- Bacteriology
Background:
- Serum resistance is a key virulence factor for many bacterial pathogens.
- Complement-mediated bactericidal activity is a crucial component of innate immunity.
- Sub-minimal inhibitory concentrations (subMICs) of antibiotics can alter bacterial physiology.
Purpose of the Study:
- To investigate if subMIC cefmetazole (CMZ) treatment can restore serum sensitivity to serum-resistant bacteria.
- To elucidate the mechanisms by which CMZ affects bacterial susceptibility to complement.
Main Methods:
- Growth of Salmonella montevideo SH5770 in subMIC cefmetazole (CMZ).
- Measurement of 125I-C3 and 125I-C9 deposition on bacteria.
- SDS-PAGE, autoradiography, indirect immunofluorescence, and ELISA for complement component analysis.
- Assessment of bacterial hydrophobicity and cell wall integrity via electron microscopy.
Main Results:
- CMZ-treated bacteria showed significantly increased deposition of C3 and C9 compared to untreated bacteria.
- SDS-PAGE confirmed enhanced formation of complement membrane attack complexes (poly-C9) on CMZ-grown bacteria.
- Bacterial hydrophobicity increased, and cell wall disruption/blebbing was observed after CMZ treatment.
- The ratio of C3b:iC3b and the nature of the C3-bacterial bond remained unchanged.
Conclusions:
- Growth in subMIC cefmetazole (CMZ) effectively renders serum-resistant Salmonella sensitive to complement-mediated killing.
- CMZ treatment enhances bacterial susceptibility by increasing cell surface hydrophobicity, facilitating membrane attack complex (C5b-9) formation and stable insertion of poly-C9.
- This study highlights a novel mechanism by which sub-antibiotic concentrations can modulate bacterial-host immune interactions.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pharmacodynamic Models: Overview
Antimicrobial Effectiveness
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis

